Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors

By de Jonge M.J.A.   Droz J.P.   Paz-Ares L.   van Oosterom A.T.   de Wit R.   Chollet P.   Baron B.   Lacombe D.   Mettinger K.   Fumoleau P.  

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 329-333

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma

By Ernst D   Eisenhauer Elizabeth   Wainman Nancy   Davis Mary   Lohmann Reinhard   Baetz Tara   Belanger Karl   Smylie Michael  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 569-575

Springer Publishing Company

Access to resources Recommend Favorite

A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane

By Ajani J.   Safran H.   Bokemeyer C.   Shah M.   Lenz H.-J.   Cutsem E.   Burris H.   Lebwohl D.   Mullaney B.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 441-446

Springer Publishing Company

Access to resources Recommend Favorite

Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer

By  

Current Clinical Pharmacology, Vol. 9, Iss. 2, 2014-05 ,pp. : 139-147

Bentham Science Publishers

Access to resources Recommend Favorite

A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

By Kim Sun   Hong Yong   Kim Byung   Park Ji   Choi Hyo   Jeong Seung-Yong   Kim Dae   Hong Chang   Sohn Dae   Jung Kyung  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite